...
首页> 外文期刊>Acta biomaterialia >In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis.
【24h】

In vitro and in vivo evaluation of chemically modified degradable starch microspheres for topical haemostasis.

机译:体外和体内化学修饰的可降解淀粉微球对局部止血的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Degradable starch microspheres (DSMs) are starch chains cross-linked with epichlorhydrin, forming glycerol-ether links. DSMs have been used for many years for temporary vascular occlusion and drug delivery in treatment of malignancies. They are also approved and used for topical haemostasis by absorbing excess fluid from the blood and concentrating endogenous coagulation factors, thereby facilitating haemostasis. This mechanism of action is not sufficient for larger bleedings in current chemical formulations of DSMs, and modification of DSMs to trigger activation of platelets or coagulation would be required for use in such applications. Chemical modifications of DSMs with N-octenyl succinic anhydride, chloroacetic acid, acetic anhydride, diethylaminoethyl chloride and ellagic acid were performed and evaluated in vitro with thrombin generation and platelet adhesion tests, and in vivo using an experimental renal bleeding model in rat. DSMs modified to activate platelets in vitro were superior in haemostatic capacity in vivo. Further studies with non-toxic substances are warranted to confirm these results and develop the DSM as a more effective topical haemostatic agent.
机译:可降解淀粉微球(DSM)是与表氯醇交联的淀粉链,形成甘油-醚键。 DSM已用于治疗恶性肿瘤的暂时性血管闭塞和药物输送已有多年历史。它们也被批准用于局部止血,可通过吸收血液中的多余液体并浓缩内源性凝血因子来促进止血。这种作用机制不足以使当前DSM的化学制剂中出现较大的出血,因此在此类应用中需要对DSM进行修饰以触发血小板活化或凝血。用N-辛烯基琥珀酸酐,氯乙酸,乙酸酐,二乙基氨基乙基氯和鞣花酸对DSM进行化学修饰,并在体外进行凝血酶生成和血小板粘附试验,并在大鼠中使用实验性肾出血模型进行体内修饰。经过修饰以在体外激活血小板的DSM在体内具有更高的止血能力。有必要对无毒物质进行进一步研究,以证实这些结果,并将DSM开发为更有效的局部止血剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号